• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Sight Sciences, Inc. - Common Stock (NQ:SGHT)

    3.960 -1.450 (-26.80%)
    Streaming Delayed Price Updated: 4:00 PM EST, Mar 5, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Sight Sciences, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 Next >
    News headline image
    A Preview Of Sight Sciences's Earnings ↗
     
    Via Benzinga
    News headline image
    Sight Sciences Launches the Ergo-Series of the OMNI® Surgical System
    The Ergo-Series maximizes ergonomics and surgical ease-of-use while continuing to enable surgeons to perform minimally invasive, implant-free glaucoma procedures 
    From Sight Sciences, Inc.
    Via GlobeNewswire
    News headline image
    Glaucoma Is The Second Leading Cause Of Blindness Globally – Skye Bioscience Appears To Be Making Rapid Progress In The Development Of Their Candidate To Treat It ↗
    Biomed company Skye Bioscience (OTCQB: SKYE) has seen positive results in its clinical research so far and is preparing for the next stage in the development of its therapy for eye disease.  
    Via Benzinga
    News headline image
    Sight Sciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 13, 2023
    From Sight Sciences, Inc.
    Via GlobeNewswire
    News headline image
    5 Analysts Have This to Say About Sight Sciences ↗
    Within the last quarter, Sight Sciences (NASDAQ:SGHT) has observed the following analyst ratings: 
    Via Benzinga
    News headline image
    Sight Sciences to Present at the Upcoming Citi 2023 Healthcare Services, Medtech, Tools & HCIT Conference
    From Sight Sciences, Inc.
    Via GlobeNewswire
    News headline image
    3 Prime Healthcare Takeover Targets ↗
    These three companies are attractive targets for their potential. 
    Via The Motley Fool
    News headline image
    Lions Gate Entertainment, DexCom, Yelp And Other Big Stocks Moving Higher On Friday ↗
    U.S. stocks traded mixed, with the Nasdaq Composite dropping around 100 points on Friday. Here are some big stocks recording losses in today’s session. 
    Via Benzinga
    News headline image
    Sight Sciences Announces 1,000th TearCare® Customer Installation
    Over 1,000 Professional Eye Care Practices Have integrated the TearCare® System to Treat Root Cause of Dry Eye Disease due to Meibomian Gland Dysfunction (MGD) 
    From Sight Sciences, Inc.
    Via GlobeNewswire
    News headline image
    Super Micro Computer, Rayonier Advanced Materials And Some Other Big Stocks Moving Lower On Tuesday ↗
    U.S. stocks traded slightly higher, with the Dow Jones gaining around 30 points on Tuesday. Here are some big stocks recording losses in today’s session. 
    Via Benzinga
    News headline image
    Sight Sciences Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial Results
    Company Also Announces CFO Transition 
    From Sight Sciences, Inc.
    Via GlobeNewswire
    News headline image
    Dow Rises Over 300 Points; US Adds 223,000 Jobs In December ↗
    U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Friday. 
    Via Benzinga
    News headline image
    Skye Bioscience (OTCQB: SKYE) Heads Into 2023 As A Clinical-Stage Company After Dosing Its First Human Participants ↗
    This year has been quite busy for Skye Bioscience Inc. (OTCQB: SKYE). 
    Via Benzinga
    News headline image
    Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
    Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process. 
    Via Benzinga
    News headline image
    Improvements in Signs and Symptoms of Dry Eye Disease From a Single TearCare® Treatment Sustained Through 12 Months
    From Sight Sciences, Inc.
    Via GlobeNewswire
    Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023 ↗
     
    Via Benzinga
    News headline image
    Sight Sciences to Present at the Upcoming Piper Sandler 34th Annual Healthcare Conference
    From Sight Sciences, Inc.
    Via GlobeNewswire
    News headline image
    Unity Software, Amazon, Doximity And Other Big Gainers From Friday ↗
    U.S. stocks closed higher on Friday, with the Nasdaq Composite jumping more than 200 points. Here is the list of some big stocks recording gains in the previous session. 
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
    Gainers 
    Via Benzinga
    News headline image
    Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday ↗
    Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 56.6% to settle at $19.10 on Friday. 
    Via Benzinga
    News headline image
    Dow Turns Higher; Nasdaq Jumps Over 200 Points ↗
    U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 60 points on Friday. 
    Via Benzinga
    News headline image
    Why Compass Shares Are Trading Higher By Over 56%? Here Are 63 Stocks Moving In Friday's Mid-Day Session ↗
    Gainers Snail, Inc. (NASDAQ: SNAL) shares jumped 74.9% to $3.9350 after the company announced a $5 million share repurchase program. 
    Via Benzinga
    News headline image
    Nasdaq Surges 100 Points; Crude Oil Rises Sharply ↗
    U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining 100 points on Friday. 
    Via Benzinga
    News headline image
    US Stocks Mixed Following Thursday's Rally; Dow Drops 50 Points ↗
    U.S. stocks traded mixed this morning on Friday, after the Dow Jones jumped 1,200 points in the previous session. 
    Via Benzinga
    News headline image
    Sight Sciences Reports Third Quarter 2022 Financial Results
    From Sight Sciences, Inc.
    Via GlobeNewswire
    News headline image
    Sight Sciences Announces Publication of Clinical Data Demonstrating Standalone Effectiveness of the OMNI® Surgical System in Pseudophakic Glaucoma Patients with Uncontrolled Pressure Following a Previous Combination Cataract Stent Procedure
    Multicenter Clinical Data from Five US sites Published in International Ophthalmology 
    From Sight Sciences, Inc.
    Via GlobeNewswire
    News headline image
    Earnings Scheduled For November 10, 2022 ↗
    Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings for its third quarter. 
    Via Benzinga
    News headline image
    Sight Sciences to Report Third Quarter 2022 Financial Results on November 10, 2022
    From Sight Sciences, Inc.
    Via GlobeNewswire
    News headline image
    Morgan Stanley Maintains Overweight Rating for Sight Sciences: Here's What You Need To Know ↗
    Morgan Stanley has decided to maintain its Overweight rating of Sight Sciences (NASDAQ:SGHT) and lower its price target from $14.00 to $10.00. Shares of Sight Sciences are trading down 3.39% over the... 
    Via Benzinga
    News headline image
    Expert Ratings for Sight Sciences ↗
    Over the past 3 months, 4 analysts have published their opinion on Sight Sciences (NASDAQ:SGHT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.